ARCHIVES

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

This article is from The Cancer Letter archive.

Vol. 17 No. 41 | October 25, 1991

Download PDF Visit The Full Archive

Related Articles

OMB Reprogramming Ban Criticized

September 20, 1985

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012

Lung Screening Study Ties Up Advisors, Board Sends It Back To NCI For Revision.

June 29, 2001

NCI Toughens Criteria for MERIT Awards

February 23, 1996

Four More Grants Planned By Prostatic Cancer Project This Year; Applications Still Accepted

August 30, 1974